INTERVIEW: Johnson & Johnson Innovation's J-Labs seeks out new ideas in Texas
This article was originally published in Scrip
Johnson & Johnson has long been an investor in early stage science, and the company is increasing its geographic reach with the launch of a new J-Labs incubator in Houston, Texas. The incubator is part of its J-Labs offering, formerly known as Janssen Labs, and will be housed within the Texas Medical Center's new Innovation Institute. Called J-Labs @TMC, it will be home to up to 50 start-ups that could come from any areas that J&J is involved in: namely, consumer, medical devices/diagnostics, and pharma.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.